Prof Yaakov Nahmias, Founder & CSO


Prof. Nahmias is director of the Grass Center for Bioengineering at the Hebrew University of Jerusalem. He is a magna cum laude graduate of The Technion, Israel Institute of Technology, did his PhD at the University of Minnesota and his postdoc at Harvard Medical School. Nahmias is a recipient of a National Institute of Health (NIH) career award, two European Research Council (ERC) grants, the Rappaport Prize for Biomedical Sciences, the Rosetrees Trust Prize for Interdisciplinary Science, and the Kaye Innovation Award. Nahmias is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and the British Royal Society of Medicine. He is an internationally recognized expert in tissue engineering and nanotechnology, and entrepreneur whose work established the first 3D cell printing and the first organ on chip technology on the market (HuREL). 


Dr. Einat Zisman
Chief Executive Officer

Over 20-years experience in entrepreneurial space. Former CEO of Hadasit and FutuRx.  


Avner Ehrlich
EVP Research & Development

Biomedical engineer and innovator and medical officer. Founder of iCough.


Dr. Yafit Stark
Director Regulatory Affairs

Over 25-year experience in regulatory affairs. Former VP of TEVA (approved Copaxone®)


Prof. Raymond Cypress

Board of Directors

Professor of microbiology & immunology. CEO of ATCC